Clinical trial
Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
NCT05802186
Study timeline
Study start (actual)2023-11-20Date precision: day
Registry last updated2026-05-29
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Lung Carcinomaunresolved
Lung Non-Small Cell Carcinomaunresolved
Stage I Lung Cancer AJCC v8unresolved
Stage II Lung Cancer AJCC v8unresolved
Stage IIIA Lung Cancer AJCC v8unresolved
Interventions
Computed TomographyPROCEDURE
Magnetic Resonance ImagingPROCEDURE
Positron Emission TomographyPROCEDURE
Stereotactic Body Radiation TherapyRADIATION
X-Ray ImagingPROCEDURE
Sponsors & collaborators
Northwestern Universitylead sponsor
Varian Medical Systemscollaborator
National Cancer Institute (NCI)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05802186 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.